Swedbank Robur Medica
- Namn
- Swedbank Robur Medica
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- Fondförmögenhet
- 10 693 047 322 SEK
- Likvida medel
- 202 713 876 SEK
- Övriga tillgångar och skulder
- 47 005 741 SEK
- Antal innehav
- 65
- Aktiv risk
- 4,11
- Standardavvikelse 24 månader
- 16,66
- Jämförelseindex
- MSCI World Health Care 10/40 Net
- Förvaltningsavgift
- 1,25% Fast
Största innehav
Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
---|---|---|---|
United Health | 780 406 042 SEK | 7,30% | Health Care |
Roche | 574 551 006 SEK | 5,37% | Health Care |
Merck | 514 007 342 SEK | 4,81% | Health Care |
Sanofi | 464 009 052 SEK | 4,34% | Health Care |
Thermo Fisher Scientific | 458 478 448 SEK | 4,29% | Health Care |
Abbott Laboratories | 453 210 320 SEK | 4,24% | Health Care |
AstraZeneca | 413 243 827 SEK | 3,86% | Health Care |
Centene | 381 928 881 SEK | 3,57% | Health Care |
Amgen | 337 710 737 SEK | 3,16% | Health Care |
Novo Nordisk | 322 391 825 SEK | 3,01% | Health Care |
Horizon Therapeutics | 314 951 002 SEK | 2,95% | Health Care |
Alexion Pharmaceuticals | 309 318 395 SEK | 2,89% | Health Care |
Takeda Pharmaceutical | 298 164 001 SEK | 2,79% | Health Care |
Vertex Pharmaceuticals | 281 349 015 SEK | 2,63% | Health Care |
Intuitive Surgical | 251 402 832 SEK | 2,35% | Health Care |
Mylan | 226 044 941 SEK | 2,11% | Health Care |
Edward Lifesciences | 220 278 602 SEK | 2,06% | Health Care |
Swedish Orphan Biovitrum | 206 150 000 SEK | 1,93% | Health Care |
Biogen | 191 115 632 SEK | 1,79% | Health Care |
Exelixis | 187 376 790 SEK | 1,75% | Health Care |
IQVIA | 182 837 442 SEK | 1,71% | Health Care |
Hologic | 179 162 046 SEK | 1,68% | Health Care |
UCB | 175 474 696 SEK | 1,64% | Health Care |
Livanova | 148 634 302 SEK | 1,39% | Health Care |
Ionis Pharmaceuticals | 136 256 030 SEK | 1,27% | Health Care |
Branscher
Källa: Finansinspektionen.